Drugs

Latest publications

Search publications

Search result publications

114 results found.

De Looze, M., Dorsselaer, S. van, Stevens, G. W. J. M., Boniel-Nissim, M., Vieno, A., & Eijnden, R. J. J. M. van den (2019). The decline in adolescent substance use across Europe and North America in the early twenty-first century: A result of the digital revolution? International Journal of Public Health, 64(2), 229-240. doi:10.1007/s00038-018-1182-7

Harris, M. G., Bharat, C., Meyer, D. Glantz, Sampson, N. A., Al-Hamzawi, A., Alonso, J., Have, M. ten . . . Degenhardt, L. (2019). Cross-national patterns of substance use disorder treatment and associations with mental disorder comorbidity in the WHO World Mental Health Surveys. Addiction, 114(8), 1446–1459. doi:10.1111/add.14599

Blankers, M., Gouwe, D. van der,& Laar, M, van (2018). 4-Fluoramphetamine in the Netherlands: Text-mining and sentiment analysis of internet forums. International Journal of Drug Policy, 64, 34-39. doi:10.1016/j.drugpo.2018.11.016

Degenhardt, L., Saha, S., Lim, C., Aguilar-Gaxiola, S., Al-Hamzawi, A., Alonso, J., ... Have, M. ten. (2018). The associations between psychotic experiences, and substance use and substance use disorders: findings from the World Health Organisation World Mental Health Surveys. Addiction, 113(5), 924-934. doi:10.1111/add.14145

Evans-Lacko, S., Aguilar-Gaxiola, S., Al-Hamzawi, A., Alonso, J., Benjet, C., Bruffaerts, R., Have, M. ten, . . . Thornicroft, G. (2018). Socio-economic variations in the mental health treatment gap for people with anxiety, mood, and substance use disorders: results from the WHO World Mental Health (WMH) surveys. Psychological Medicine, 48(9), 1560-1571. doi:10.1017/S0033291717003336

Freeman, T.P., Pol, P. van der, Kuijpers, W., Wisselink, J., Da, R.K., Rigter, R., Laar, M. van, ... Niesink, R. (2018). Changes in cannabis potency and first-time admissions to drug treatment: a 16-year study in the Netherlands. Psychological Medicine. doi:10.1017/S0033291717003877

Kraus, L., Seitz, N-N., Piontek, D., Molinaro, S., Siciliano, V., Guttormsson, U., Monshouwer, K. . . . Hibell, B. (2018). “Are The Times A-Changin”? Trends in adolescent substance use in Europe. Addiction, 113(7), 1317-1332. doi:10.1111/add.14201

Molinaro, S., Benedetti, E., Scalese, M., Bastiani, L., Fortunato, L., Cerrai, S., Monshouwer, K., . . . Urdih Lazar, T. (2018). Prevalence of youth gambling and potential influence of substance use and other risk factors across 33 European countries: First results from the 2015 ESPAD study. Addiction, 113(10), 1862-1873. Doi:10.1111/add.14275

Sourbron, J., Chan, H., Wammes-van der Heijden, E. A., Klarenbeek, P., Wijnen, B. F. M., de Haan, G. J., . . . Majoie, M. (2018). Review on the Relevance of Therapeutic Drug Monitoring of Levetiracetam. Seizure, 62, 131-135. doi:10.1016/j.seizure.2018.09.004

Berman, A.H., Hoybye, M.T., & Blankers, M. (2017). Editorial on IJBM Special Issue—E-Health Interventions for Addictive Behaviors. International Journal of Behavioral Medicine, 24(5), 641-645. doi:10.1007/s12529-017-9684-x

Blankers, M. & Mujcic, A. (2017). E-health and m-health: using new technologies to respond to drug problems. EMCDDA Drugs Library.

Broek, F. van & Croes, E. (2017). Zeggen alle tieners ja tegen mdma? Informatief, 23(2).

Brunt, T.M., Atkinson, A.M., Nefau, T., Martinez, M., Lahaie, E., Malzcewdki, A. ... Brandt, S.D. (2017). Online test purchased new psychoactive substances in 5 different European countries: a snapshot study of chemical composition and price. The International Journal of Drug Policy, 44(mei). doi:10.1016/j.drugpo.2017.03.006

Brunt, T.M., Berg, J. van den, Pennings, E., & B. Venhuis (2017). Adverse effects of levamisole in cocaine users: a review and risk assessment. Archives of Toxicology, 91(6), 2303-2313. doi:10.1007/s00204-017-1947-4

Degenhardt, L., Glantz, M., Evans-Lacko, S., Sadikova, E., Sampson, N., Thornicroft, G., Have, M. ten, . . . Kessler, R.C. on behalf of the World Health Organization’s Mental Health Surveys collaborators. (2017). Estimating treatment coverage for people with substance use disorders: An analysis of data from the World Mental Health Surveys.. World Psychiatry, 16(3), 299-307. doi:10.1002/wps.20457

European Union HCV Collaborators (2017). Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study. The Lancet Gastroenterology & Hepatology, 2(5), 325-336. doi:10.1016/S2468-1253(17)30045-6

Gee, A. de, croes, E., Putten, J. van, & Poel, A. van der (2017). Hepatitis C: alles uit de kast. Medisch Contact(mei), 21-23.

Giné, C.V., Vilamala, M.V., Measham, F., Brunt, T.M., Bücheli, A., Paulos, C., ... Barratt, M.J. (2017). The utility of drug checking services as monitoring tools and more: a response to Pirona et al. The International Journal of Drug Policy(45), 46-47. doi:10.1016/j.drugpo.2017.05.018

Gouwe, D. van der, Rigter, S., & Brunt, T.M. (2017). Focus on cryptomarkets and online reviews too narrow to debate harms of drugs bought online. Addiction(november). doi:10.1111/add.14060

Helsper, C.W., Janssen, M.P., Essen, G.A. van, Croes, E.A., Veen, C. van der, Wit, A.G. de, & Wit, N.J.de (2017). Effectiveness and cost-effectiveness of nationwide campaigns for awareness and case finding of hepatitis C targeted at people who inject drugs and the general population in the Netherlands. The International Journal of Drug Policy(47), 117-125. doi:10.1016/j.drugpo.2017.07.022

Recent publications